Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial

D.L. Kendler, F. Marin, P. Geusens, P. Lopez-Romero, E. Lespessailles, J.J. Body, S. Minisola

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number115113
Number of pages10
JournalBone
Volume130
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • anti-depressant
  • antidepressant use
  • benzodiazepine
  • benzodiazepines
  • bisphosphonate
  • bisphosphonates
  • bone-mineral density
  • fracture
  • older-adults
  • postmenopausal women
  • prescription
  • proton pump inhibitor
  • recurrent falls
  • serotonin reuptake inhibitors
  • teriparatide
  • therapy
  • BONE-MINERAL DENSITY
  • Fracture
  • Proton pump inhibitor
  • SEROTONIN REUPTAKE INHIBITORS
  • BISPHOSPHONATES
  • THERAPY
  • RECURRENT FALLS
  • PRESCRIPTION
  • ANTIDEPRESSANT USE
  • POSTMENOPAUSAL WOMEN
  • Bisphosphonate
  • OLDER-ADULTS
  • Benzodiazepine
  • BENZODIAZEPINES
  • Teriparatide
  • Anti-depressant

Cite this